e.g. mhealth
Search Results (1 to 5 of 5 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 2 JMIR Research Protocols
- 1 Interactive Journal of Medical Research
- 1 JMIR Formative Research
- 1 JMIR Public Health and Surveillance
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Diabetic retinopathy (DR) is a prevalent and severe microvascular complication of diabetes mellitus (DM) [1]. In India, 10.9% (7.2%‐16.3%) of individuals aged 65 years and above with diabetes have DR, with 2.3% (1.2%‐4.4%) suffering from vision-threatening diabetic retinopathy (VTDR) [1], characterized by severe retinopathy or macular edema [2]. DR is typically asymptomatic in its early stages, and it can lead to visual impairment or blindness if left untreated [3].
JMIR Form Res 2025;9:e67047
Download Citation: END BibTex RIS
Diabetic retinopathy (DR) has a profound presence in medicine and ophthalmology. It is one of the most common complications of diabetes mellitus (DM), attacking many areas of the body and causing issues like end-stage renal disease and cardiovascular illness [1].
JMIR Res Protoc 2024;13:e57292
Download Citation: END BibTex RIS
This classification divides the diagnosis of diabetic retinopathy into 5 stages: no diabetic retinopathy, mild nonproliferative diabetic retinopathy, moderate nonproliferative diabetic retinopathy, severe nonproliferative diabetic retinopathy, and proliferative diabetic retinopathy.
JMIR Public Health Surveill 2021;7(3):e23538
Download Citation: END BibTex RIS
For people living with diabetes worldwide, diabetic retinopathy is the most common complication and is also a critical microvascular complication [4-6]. This vascular disease of the retina comprises three forms: nonproliferative diabetic retinopathy, macular edema and ischemia, and proliferative diabetic retinopathy.
JMIR Res Protoc 2020;9(2):e15109
Download Citation: END BibTex RIS
However, retinopathy debatably remains HCQ’s most feared adverse effect. The mechanism of HCQ-induced retinopathy is not fully known, but buildup in the retinal pigment epithelium could cause this condition [8]. Recently, the prevalence of HCQ-induced retinopathy was estimated to be higher than that assumed earlier (7.5%) [9].
Interact J Med Res 2019;8(4):e15218
Download Citation: END BibTex RIS